In this issue, we are asking for your reactions in four areas: the ramificationas of the ongoing review of NIH intrramural research programs; the proper role of patenting and commercialization in a government research facility, the impact of bans on research related to human embryos and cloninh, and the ever-popular "Hot Methods Clinic."

Send your responses on these topics or your comments on other intramural research concerns to us via e-mail:
<catalyst@nih.gov>; fax:402-4303; or mail: Building 1, Room 334.

In Future Issues...

Stem Cells, Sequencing Find Campus Homes

Bioethics and Bans

Clinical Research: The Way Up

1.Do you think implementing the NIMH recommendations will restore a proper balance? Why or why not? Could other institutes benefit from some of these changes?

2.How prominently does the urge to "invent" figure in your own research priorities?

3.How do recent bans on the use of federal funds for research on human cloning and on certain types of human-embryo research affect NIH's research agenda?

4.What's been your experience with the "cool" BIA method presented in this last issue? Any suggestion—hot or cool—for a future "Hot Methods Clinic"?